Mexico grants emergency use approval for Merck's COVID-19 pill - Reuters

serongyu.blogspot.com

An experimental COVID-19 treatment pill, called molnupiravir and being developed by Merck & Co Inc and Ridgeback Biotherapeutics LP, is seen in this undated handout photo released by Merck & Co Inc and obtained by Reuters May 17, 2021. Merck & Co Inc/Handout via REUTERS

MEXICO CITY, Jan 7 (Reuters) - Mexico's health regulator has granted authorization for emergency use of drugmaker Merck's (MRK.N) COVID-19 pill Molnupiravir, President Andres Manuel Lopez Obrador said on Friday.

The health regulator, COFEPRIS, confirmed the approval in a statement later in the day.

COFEPRIS was expected to soon also approve Pfizer's (PFE.N) Paxlovid pill to treat COVID-19, Lopez Obrador added at a regular news conference. Both medications were approved last month in the United States.

Molnupiravir was developed with Ridgeback Biotherapeutics and shown to reduce hospitalizations and deaths by around 30% in a clinical trial of high-risk individuals early in the course of the illness.

Lopez Obrador said he planned to make both medications available in public hospitals.

Register now for FREE unlimited access to Reuters.com

Reporting by Daina Beth Solomon Editing by Dave Graham and Sandra Maler

Our Standards: The Thomson Reuters Trust Principles.

Adblock test (Why?)

"use" - Google News
January 08, 2022 at 08:11AM
https://ift.tt/34jR43h

Mexico grants emergency use approval for Merck's COVID-19 pill - Reuters
"use" - Google News
https://ift.tt/2P05tHQ
https://ift.tt/2YCP29R

Bagikan Berita Ini